Medical Products
Supported by a strong commitment to science and the resources necessary for
true innovation, Abbott has leading products and novel R&D capabilities
focused on unmet medical needs. These include laboratory and molecular
diagnostics for detecting and monitoring a wide variety of medical
conditions; glucose monitoring for patients with diabetes; vascular devices
such as coronary and carotid stents.
Our broad offering of medical and surgical devices focuses on
minimally invasive, fast and accurate treatment options that offer short
recovery times and ultimately improve patient care. Abbott's vascular
business is poised for outstanding growth with support from our acquisition
of Guidant Corporation's vascular intervention and endovascular solutions
businesses.
Abbott is an emerging leader in molecular diagnostics, one of the
most promising new areas of medicine. By analyzing DNA, RNA and proteins at the
molecular level, our leading-edge science and technologies are helping
physicians diagnose disease faster, select appropriate therapies and monitor
disease progression. Abbott's molecular diagnostics business has gained access
to significant discovery resources with the acquisition of Vysis and the
long-term, strategic alliance formed with Celera.
We've made key acquisitions that have resulted in market-leading
products, and we've acquired outstanding technologies for the future, such as
bioabsorbable stents and continuous glucose monitoring.
Our partners have helped us support the following areas of Abbott's medical
business:
|
Vascular Devices |
| Technology and/or products: |
Resulting from a successful partnership with the following: |
| Vascular closure device |
Perclose, Inc. |
| Carotid stent system |
MedNova |
| Vascular devices |
JOMED |
| Vascular closure device |
Integrated Vascular Solutions, Inc. |
| Coronary and peripheral interventional products |
Guidant |
| Coronary guidewires |
ASAHI INTECC Co., Ltd. |
| Molecular Diagnostics
and Diabetes Care |
| Acquired technology and/or products: |
Resulting from a successful partnership with the following: |
| Blood glucose self-monitoring system |
TheraSense |
| Genomic technology |
Celera Diagnostics |
| Genomic technology |
Vysis, Inc. |
| Infectious disease technology |
Ibis Biosciences, Inc. |
| Vision Care |
| Acquired technology and/or products: |
Resulting from a successful partnership with the
following: |
| Corneal, refractive and cataract products |
Advanced Medical Optics, Inc. |